Default company panoramic image
89d3100f 8e64 4f18 a9ea fc43d1933a10

Genome Surveillance, LLC.

Genome Surveillance is developing fast and accurate "scaffold sequencing" technology for accurate sequence assembly, genome analysis and molecular diagnosis.

  • Stage Concept Only
  • Industry Biotechnology
  • Location Madison, WI, US
  • Currency USD
  • Founded September 2015
  • Employees 3

Company Summary

Genome Surveillance, LLC, is in a process to develop and commercialize the “scaffold sequencing” technology. The challenges that the "scaffold sequencing" technology is addressing in the DNA sequencing world are: i. to accurately assemble de novo genome sequences using next-generation sequencing short reads; ii. to detect long range genomic structure variations, and phase haplotypic variants; iii. to sort out individual genomes in microbial metagenome and plant polyploidy genome next-generation sequencing data; and iv. to rapidly genotype for molecular diagnosis of diseases to improve human health and for the identification of genomic trait variants in agriculture. Our future products will include instruments and associated consumables, software and services. As ~80% of current genome sequencing projects needs help from our “scaffold sequencing” system, we believe that our “scaffold sequencing” system will become one of the main DNA sequencing platforms in near future.

Team

  • 75d6c2ef 8ff6 4ee9 b6b2 1e2aa07e7197
    President/CSO

    Exceptional research scientist with 10+ years of molecular biology, genomics, and micro-/nano-biotechnology development. Skilled in single molecular mapping, sequencing, and analysis of single molecular maps and sequences to discover and characterize genome structural variants; Authored or coauthored 40 scientific papers and 2 single molecular analysis patents.

Previous Investors